|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
STOK | Kaye Edward M. MD | Director | Mar 18 '25 | Sale | 8.67 | 10,382 | 90,012 | 148,253 | Mar 20 06:15 PM |
STOK | Kaye Edward M. MD | Director | Mar 19 '25 | Sale | 8.27 | 8,907 | 73,661 | 139,346 | Mar 20 06:15 PM |
STOK | Kaye Edward M. MD | CEO | Mar 15 '25 | Option Exercise | 0.00 | 61,750 | 0 | 158,635 | Mar 18 04:07 PM |
STOK | Kaye Edward M. MD | CEO | Dec 30 '24 | Option Exercise | 0.60 | 35,000 | 21,000 | 96,885 | Jan 02 04:14 PM |
STOK | Kaye Edward M. MD | CEO | Dec 09 '24 | Sale | 12.99 | 6,786 | 88,158 | 61,885 | Dec 11 04:04 PM |
STOK | Kaye Edward M. MD | CEO | Dec 06 '24 | Sale | 12.78 | 6,170 | 78,837 | 68,671 | Dec 10 07:00 PM |
STOK | Kaye Edward M. MD | CEO | Dec 03 '24 | Option Exercise | 0.00 | 26,500 | 0 | 75,091 | Dec 05 04:20 PM |
STOK | Kaye Edward M. MD | CEO | Dec 01 '24 | Option Exercise | 0.00 | 21,591 | 0 | 48,591 | Dec 03 04:13 PM |
STOK | Kaye Edward M. MD | CEO | May 20 '24 | Sale | 15.43 | 42,350 | 653,529 | 27,000 | May 22 04:17 PM |
STOK | Kaye Edward M. MD | CEO | Mar 15 '24 | Option Exercise | 0.00 | 35,500 | 0 | 80,500 | Mar 19 08:30 PM |
STOK | Kaye Edward M. MD | CEO | Mar 19 '24 | Sale | 6.10 | 11,150 | 67,999 | 69,350 | Mar 19 08:30 PM |
STOK | Kaye Edward M. MD | CEO | Mar 27 '23 | Option Exercise | 0.60 | 20,000 | 12,000 | 45,000 | Sep 08 04:15 PM |
CYTK | Kaye Edward M. MD | Director | Aug 05 '22 | Option Exercise | 8.75 | 11,428 | 99,995 | 24,004 | Aug 08 04:01 PM |
CYTK | Kaye Edward M. MD | Director | Aug 05 '22 | Sale | 50.00 | 11,428 | 571,400 | 12,576 | Aug 08 04:01 PM |
STOK | Kaye Edward M. MD | CEO | May 25 '22 | Option Exercise | 0.60 | 15,000 | 9,000 | 25,000 | May 26 05:16 PM |
CYTK | Kaye Edward M. MD | Director | Dec 23 '21 | Option Exercise | 7.61 | 15,000 | 114,150 | 21,765 | Dec 23 07:11 PM |
CYTK | Kaye Edward M. MD | Director | Dec 23 '21 | Sale | 45.00 | 15,000 | 675,000 | 6,765 | Dec 23 07:11 PM |
STOK | Kaye Edward M. MD | CEO | Dec 30 '20 | Option Exercise | 0.60 | 10,000 | 6,000 | 10,000 | Jan 04 06:33 PM |
STOK | Kaye Edward M. MD | CEO | Dec 17 '20 | Sale | 60.00 | 19,806 | 1,188,360 | 5,194 | Dec 18 09:07 PM |
STOK | Kaye Edward M. MD | CEO | Dec 18 '20 | Sale | 60.00 | 5,194 | 311,640 | 0 | Dec 18 09:07 PM |
STOK | Kaye Edward M. MD | CEO | Nov 27 '20 | Sale | 50.00 | 12,152 | 607,600 | 25,000 | Nov 30 05:11 PM |
STOK | Kaye Edward M. MD | CEO | Nov 25 '20 | Sale | 50.00 | 12,848 | 642,400 | 37,152 | Nov 25 05:16 PM |
CYTK | Kaye Edward M. MD | Director | Oct 05 '20 | Option Exercise | 7.61 | 20,000 | 152,200 | 20,000 | Oct 05 08:38 PM |
CYTK | Kaye Edward M. MD | Director | Oct 05 '20 | Sale | 30.00 | 20,000 | 600,000 | 0 | Oct 05 08:38 PM |
STOK | Kaye Edward M. MD | CEO | Dec 16 '19 | Option Exercise | 0.60 | 50,000 | 30,000 | 50,000 | Apr 15 07:27 PM |
SRPT | Kaye Edward M. MD | Director | Jul 20 '17 | Sale | 41.00 | 10,000 | 410,000 | 52,471 | Jul 21 09:48 PM |
SRPT | Kaye Edward M. MD | President, CEO & CMO | Nov 09 '16 | Option Exercise | 8.28 | 3,000 | 24,840 | 75,635 | Nov 10 08:19 AM |
SRPT | Kaye Edward M. MD | President, CEO & CMO | Sep 22 '16 | Option Exercise | 8.28 | 40,179 | 332,682 | 117,162 | Sep 26 04:23 PM |
SRPT | Kaye Edward M. MD | President, CEO & CMO | Sep 22 '16 | Sale | 60.00 | 40,179 | 2,410,740 | 76,983 | Sep 26 04:23 PM |
SRPT | Kaye Edward M. MD | President, CEO & CMO | Sep 19 '16 | Option Exercise | 6.94 | 24,352 | 168,941 | 89,983 | Sep 21 09:29 PM |
SRPT | Kaye Edward M. MD | President, CEO & CMO | Sep 19 '16 | Sale | 50.00 | 24,352 | 1,217,600 | 76,983 | Sep 21 09:29 PM |
SRPT | Kaye Edward M. MD | SVP Interim CEO & CMO | Sep 14 '16 | Sale | 30.00 | 24,557 | 736,710 | 76,983 | Sep 16 04:04 PM |
SRPT | Kaye Edward M. MD | SVP & Chief Medical Officer | Feb 27 '15 | Buy | 11.81 | 800 | 9,452 | 1,311 | Mar 03 06:48 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite